Business news with perspective

Home Federal Bancorp posted a 19.5% profit increase, but underlying deposit outflows and a reliance on wholesale funding reveal a shifting banking landscape.

Slide Insurance pairs massive capital returns with a billion-dollar debt facility as it expands its AI-driven underwriting from Florida to California.

As regional banks battle deposit costs, NBT Bancorp delivers record earnings, widens its margin, and hikes its dividend for the 14th consecutive year.

DMC Global’s Q3 earnings reveal how targeted restructuring and a strategic pivot toward defense and geothermal sectors are neutralizing commercial headwinds.

National University's Nuevo Futuro Scholarship highlights a critical need to fix the institutional aid gap for working Hispanic adult learners.

Retail prop trading has long suffered a crisis of trust. By locking rules and reserves on a public blockchain, a new firm is forcing the industry to show its receipts.

As consumers seek longer, healthier lives, a regulatory grey area leaves them vulnerable. One brand hopes radical transparency can rebuild public trust.

Lee Enterprises is blending local journalism with corporate sponsorships in a new Nebraska travelogue, reshaping regional media's revenue playbook.

As AI and clinical trials demand more data, a British social enterprise is betting that explicit patient consent is the key to cracking the US market.

Addition Therapeutics is bypassing the limitations of AAV vectors with a novel RNA-based gene insertion platform, targeting obesity and rare diseases.

B&H's launch of the amaran Cam 4K signals a major shift in creator hardware, blending optics and smart lighting to automate the home studio experience.

By securing CoinDesk’s flagship event, Hong Kong aggressively positions itself as the nexus of digital assets, AI, and global capital flows.

Life Extension partners with biotech pioneer Intralytix to bring targeted bacteriophages to the supplement aisle, modernizing urinary health.

Mike Schenck's shift from Westmark CEO to TopLine's Chief Lending Officer signals a strategic push to strengthen local economic resilience in Minnesota.

As global biopharma dealmaking rebounds to record highs, European innovators face a critical funding gap that threatens to export their best science.

As synthetic pesticides face mounting regulatory pressure and chemical resistance, a projected $43 billion market for agricultural biologicals is reshaping farming.

Grön's rapid expansion into three new states highlights how strategic consolidation and minor cannabinoids are reshaping the cannabis edibles market.

ISS backs a split board at Ethan Allen, rejecting a full activist takeover. The furniture maker's debt-free balance sheet proved too strong to fully dismantle.

Egetis Therapeutics has launched the first FDA-approved therapy for MCT8 deficiency, but navigating the commercial and clinical realities of ultra-rare diseases requires more than just scientific innovation.

MarketWise announces a $0.45 quarterly dividend, highlighting how Up-C corporate tax structures fuel payouts despite shifting retail subscriber trends.